Concord Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 6, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	192,065	159,100	-	-	-	-
Enterprise Value	189,346	157,079	-	-	-	-
Last Close Price	1835.90	1512.33	-	-	-	-
PE Ratio	61.32	51.35	-	-	-	-
PS Ratio	18.50	15.65	-	-	-	-
PB Ratio	12.58	10.42	-	-	-	-
P/FCF Ratio	-	88.50	-	-	-	-
P/OCF Ratio	-	59.93	-	-	-	-
EV/Sales Ratio	18.24	15.45	-	-	-	-
EV/EBITDA Ratio	42.29	35.81	-	-	-	-
EV/EBIT Ratio	48.00	40.61	-	-	-	-
EV/FCF Ratio	-	87.37	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.02	0.06	0.09	0.07
Debt / EBITDA Ratio	0.02	0.02	0.09	0.22	0.27	0.24
Debt / FCF Ratio	-	0.05	0.31	1.19	-2.39	-83.55
Asset Turnover	-	0.63	0.60	0.57	0.58	-
Inventory Turnover	-	1.16	0.94	0.99	0.88	-
Quick Ratio	-	4.55	2.43	2.71	3.92	3.45
Current Ratio	-	6.30	3.79	4.08	5.74	4.68
Return on Equity (ROE)	-	21.88%	20.06%	16.64%	26.55%	-
Return on Assets (ROA)	-	15.04%	13.26%	11.47%	17.80%	-
Return on Capital (ROIC)	17.31%	16.92%	15.07%	12.70%	19.78%	-
Earnings Yield	1.63%	1.94%	-	-	-	-
FCF Yield	1.13%	-	-	-	-
Dividend Yield	0.48%	0.58%	-	-	-	-
Payout Ratio	0.00%	23.19%	22.31%	40.31%	2.43%	47.63%
Total Shareholder Return	0.49%	0.58%	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.